{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:24:54Z","timestamp":1792783494781,"version":"4.5.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Alma Mater Studiorum - Universit\u00e0 di Bologna","id":[{"id":"https:\/\/ror.org\/01111rn36","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Polycystic ovary syndrome (PCOS) is a common and highly heterogeneous endocrine\u2013metabolic disorder. The Rotterdam criteria identify four diagnostic phenotypes; however, it remains unclear whether these phenotypes or body mass index (BMI) better predict metabolic risk. The PCOSOUTCOME.net registry collects data from multiple Italian centers and provides an opportunity to compare the effectiveness of Rotterdam phenotypes versus BMI in characterizing the clinical, metabolic, and psychological heterogeneity of women with PCOS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We included 1,314 Caucasian women of reproductive age with PCOS. Participants were stratified according to Rotterdam phenotypes and BMI categories (normal weight, overweight, and obesity; and BMI\u2009&lt;\u200927\u00a0kg\/m\u00b2 vs.\u2009\u2265\u200927\u00a0kg\/m\u00b2). Clinical, hormonal, metabolic, gynecological, and psychological parameters were assessed and compared across subgroups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>No significant differences in BMI or in the prevalence of metabolic complications (dyslipidemia, glucose intolerance, hypertension, and metabolic syndrome) were observed among the four Rotterdam phenotypes, although anxiety scores were highest in phenotype A. In contrast, BMI-based stratification identified clear differences in metabolic markers: women with obesity or a BMI\u2009\u2265\u200927\u00a0kg\/m\u00b2 showed a higher prevalence of all metabolic complications, as well as higher free androgen index (FAI) and hirsutism scores.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In this multicenter cohort, Rotterdam phenotypes failed to discriminate metabolic risk, whereas BMI-based stratification proved more informative in identifying cardiometabolic complications. Moreover, obesity in PCOS identifies a distinct hyperandrogenic phenotype. These findings underscore the need to integrate BMI into the classification of PCOS to better capture patient heterogeneity, with potential implications for metabolic assessment and risk stratification.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s40618-026-02946-9","type":"journal-article","created":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T09:40:42Z","timestamp":1787910042000},"page":"2813-2823","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Body mass index outperforms the Rotterdam criteria in defining phenotypic heterogeneity in polycystic ovary syndrome: a multicenter study from the Italian PCOS registry (PCOSOUTCOME.net)"],"prefix":"10.1007","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2242-6734","authenticated-orcid":false,"given":"Alessandra","family":"Gambineri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0522-5017","authenticated-orcid":false,"given":"Silvia","family":"Federici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1472-6051","authenticated-orcid":false,"given":"Elisa","family":"Maseroli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-6003-8075","authenticated-orcid":false,"given":"Laura","family":"Guccione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5454-6074","authenticated-orcid":false,"given":"Marco","family":"Bonomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8116-3968","authenticated-orcid":false,"given":"Anna Maria","family":"Fulghesu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8713-3532","authenticated-orcid":false,"given":"Roberta","family":"Giordano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Mioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9632-1348","authenticated-orcid":false,"given":"Rosario","family":"Pivonello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0393-2280","authenticated-orcid":false,"given":"Laura","family":"Rotolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1526-6832","authenticated-orcid":false,"given":"Chiara","family":"Sabbadin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9396-3815","authenticated-orcid":false,"given":"Carla","family":"Scaroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5431-5823","authenticated-orcid":false,"given":"Massimo","family":"Tonacchera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4764-544X","authenticated-orcid":false,"given":"Herbert","family":"Valensise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8509-0409","authenticated-orcid":false,"given":"Nunzia","family":"Verde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0907-0630","authenticated-orcid":false,"given":"Linda","family":"Vignozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3951-0297","authenticated-orcid":false,"given":"Paolo","family":"Moghetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4006-2575","authenticated-orcid":false,"given":"Costanzo","family":"Moretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,28]]},"reference":[{"key":"2946_CR1","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1007\/s00404-024-07607-x","volume":"310","author":"N Salari","year":"2024","unstructured":"Salari N, Nankali A, Ghanbari A et al (2024) Global prevalence of polycystic ovary syndrome in women worldwide: a comprehensive systematic review and meta-analysis. Arch Gynecol Obstet 310:1303\u20131314. https:\/\/doi.org\/10.1007\/s00404-024-07607-x","journal-title":"Arch Gynecol Obstet"},{"issue":"1","key":"2946_CR2","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41572-024-00511-3","volume":"10","author":"E Stener-Victorin","year":"2024","unstructured":"Stener-Victorin E, Teede H, Norman RJ et al (2024) Polycystic ovary syndrome. Nat Rev Dis Primers 10(1):27. https:\/\/doi.org\/10.1038\/s41572-024-00511-3","journal-title":"Nat Rev Dis Primers"},{"key":"2946_CR3","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1093\/ejendo\/lvaf027","volume":"192","author":"A Gambineri","year":"2025","unstructured":"Gambineri A, Rosa S, Pandurevic S et al (2025) Evolution of cardiovascular risk factors and the risk for cardiovascular events in a Caucasian population with polycystic ovary syndrome. Eur J Endocrinol 192:210\u2013219. https:\/\/doi.org\/10.1093\/ejendo\/lvaf027","journal-title":"Eur J Endocrinol"},{"key":"2946_CR4","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/s41574-024-01057-w","volume":"21","author":"N Helvaci","year":"2025","unstructured":"Helvaci N, Yildiz BO (2025) Polycystic ovary syndrome as a metabolic disease. Nat Rev Endocrinol 21:230\u2013244. https:\/\/doi.org\/10.1038\/s41574-024-01057-w","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"2946_CR5","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1186\/s12916-025-04221-9","volume":"23","author":"AD Bizuneh","year":"2025","unstructured":"Bizuneh AD, Kiconco S, Earnest A et al (2025) The PCOS Phenotypes in Unselected Populations (P-PUP) study: participant clinical features and data harmonization on analysis of individual participant data. BMC Med 23(1):420. https:\/\/doi.org\/10.1186\/s12916-025-04221-9","journal-title":"BMC Med"},{"key":"2946_CR6","doi-asserted-by":"publisher","first-page":"176","DOI":"10.3949\/ccjm.93a.25090","volume":"93","author":"N Sung","year":"2026","unstructured":"Sung N, Amir J, Alwahab UA, Falcone T (2026) Polycystic ovary syndrome: An update on diagnosis and management. Cleve Clin J Med 93:176\u2013183. https:\/\/doi.org\/10.3949\/ccjm.93a.25090","journal-title":"Cleve Clin J Med"},{"key":"2946_CR7","doi-asserted-by":"publisher","unstructured":"Ma YC, Law KS, Wang WS, Chang HM (2025) Phenotypic variations in polycystic ovary syndrome: metabolic risks and emerging biomarkers. J Endocrinol 267(1):e250226. https:\/\/doi.org\/10.1530\/JOE-25-0226. PMID: 40970375","DOI":"10.1530\/JOE-25-0226"},{"issue":"10","key":"2946_CR8","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.3390\/diagnostics12102313","volume":"12","author":"E Carmina","year":"2022","unstructured":"Carmina E, Lobo RA (2022) Comparing Lean and Obese PCOS in Different PCOS Phenotypes: Evidence That the Body Weight Is More Important than the Rotterdam Phenotype in Influencing the Metabolic Status. Diagnostics (Basel) 12(10):2313. https:\/\/doi.org\/10.3390\/diagnostics12102313","journal-title":"Diagnostics (Basel)"},{"key":"2946_CR9","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","volume":"81","author":"BCJM Fauser","year":"2004","unstructured":"Fauser BCJM (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81:19\u201325. https:\/\/doi.org\/10.1016\/j.fertnstert.2003.10.004","journal-title":"Fertil Steril"},{"key":"2946_CR10","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/0002-9378(81)90746-8","volume":"140","author":"R Hatch","year":"1981","unstructured":"Hatch R, Rosenfield RL, Kim MH, Tredway D (1981) Hirsutism: Implications, etiology, and management. Am J Obstet Gynecol 140:815\u2013830. https:\/\/doi.org\/10.1016\/0002-9378(81)90746-8","journal-title":"Am J Obstet Gynecol"},{"key":"2946_CR11","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","volume":"16","author":"K Kroenke","year":"2001","unstructured":"Kroenke K, Spitzer RL, Williams JBW (2001) The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 16:606\u2013613. https:\/\/doi.org\/10.1046\/j.1525-1497.2001.016009606.x","journal-title":"J Gen Intern Med"},{"key":"2946_CR12","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","volume":"166","author":"RL Spitzer","year":"2006","unstructured":"Spitzer RL, Kroenke K, Williams JBW, L\u00f6we B (2006) A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med 166:1092\u20131097. https:\/\/doi.org\/10.1001\/archinte.166.10.1092","journal-title":"Arch Intern Med"},{"key":"2946_CR13","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1080\/009262300278597","volume":"26","author":"R Rosen","year":"2000","unstructured":"Rosen R, Brown C, Heiman J et al (2000) The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther 26:191\u2013208. https:\/\/doi.org\/10.1080\/009262300278597","journal-title":"J Sex Marital Ther"},{"key":"2946_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF03327738","volume":"11","author":"M Cuzzolaro","year":"2006","unstructured":"Cuzzolaro M, Vetrone G, Marano G, Garfinkel PE (2006) The Body Uneasiness Test (BUT): development and validation of a new body image assessment scale. Eat Weight Disord 11:1\u201313. https:\/\/doi.org\/10.1007\/BF03327738","journal-title":"Eat Weight Disord"},{"key":"2946_CR15","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.fertnstert.2023.07.025","volume":"120","author":"HJ Teede","year":"2023","unstructured":"Teede HJ, Tay CT, Laven J et al (2023) Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. Fertil Steril 120:767\u2013793. https:\/\/doi.org\/10.1016\/j.fertnstert.2023.07.025","journal-title":"Fertil Steril"},{"issue":"1","key":"2946_CR16","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41366-025-01922-2","volume":"50","author":"S Al Busaidi","year":"2026","unstructured":"Al Busaidi S, Al-Maqbali JS, Al Nou\u2019mani J, Al Harthi T, Al Alawi AM, Al Kharusi A (2026) Optimal BMI cut-offs associated with cardiometabolic risks in Arab and Middle Eastern populations: a systematic review and meta-analysis. Int J Obes (Lond) 50(1):23\u201332. https:\/\/doi.org\/10.1038\/s41366-025-01922-2","journal-title":"Int J Obes (Lond)"},{"key":"2946_CR17","doi-asserted-by":"publisher","unstructured":"American Diabetes Association Professional Practice Committee Diagnosis and Classification of Diabetes: Standards of Care in Diabetes-2025. Diabetes Care 1 January 2025; 48 (Supplement_1): S27\u2013S49. https:\/\/doi.org\/10.2337\/dc25-S002","DOI":"10.2337\/dc25-S002"},{"key":"2946_CR18","doi-asserted-by":"publisher","unstructured":"Cleeman JI, The Third Report of The National Cholesterol Education Program (NCEP) (2001) Executive Summary of Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 285:2486\u20132497. https:\/\/doi.org\/10.1001\/jama.285.19.2486","DOI":"10.1001\/jama.285.19.2486"},{"key":"2946_CR19","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS et al (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412\u2013419. https:\/\/doi.org\/10.1007\/BF00280883","journal-title":"Diabetologia"},{"key":"2946_CR20","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.1093\/humrep\/dex308","volume":"1","author":"F Tosi","year":"2017","unstructured":"Tosi F, Bonora E, Moghetti P (2017) Insulin resistance in a large cohort of women with polycystic ovary syndrome: a comparison between euglycaemic-hyperinsulinaemic clamp and surrogate indexes. Hum Reprod 1:32:2515\u20132521. https:\/\/doi.org\/10.1093\/humrep\/dex308","journal-title":"Hum Reprod"},{"issue":"1","key":"2946_CR21","doi-asserted-by":"publisher","first-page":"e250226","DOI":"10.1530\/JOE-25-0226","volume":"267","author":"YC Ma","year":"2025","unstructured":"Ma YC, Law KS, Wang WS, Chang HM (2025) Phenotypic variations in polycystic ovary syndrome: metabolic risks and emerging biomarkers. J Endocrinol 267(1):e250226. https:\/\/doi.org\/10.1530\/JOE-25-0226","journal-title":"J Endocrinol"},{"issue":"4","key":"2946_CR22","doi-asserted-by":"publisher","first-page":"E628","DOI":"10.1210\/jc.2012-3908","volume":"98","author":"P Moghetti","year":"2013","unstructured":"Moghetti P, Tosi F, Bonin C et al (2013) Divergences in insulin resistance between the different phenotypes of the polycystic ovary syndrome. J Clin Endocrinol Metab 98(4):E628\u2013E637. https:\/\/doi.org\/10.1210\/jc.2012-3908","journal-title":"J Clin Endocrinol Metab"},{"key":"2946_CR23","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1530\/EJE-16-0775","volume":"175","author":"I Bo\u017ei\u0107-Anti\u0107","year":"2016","unstructured":"Bo\u017ei\u0107-Anti\u0107 I, Ili\u0107 D, Bjeki\u0107-Macut J et al (2016) Lipid accumulation product as a marker of cardiometabolic susceptibility in women with different phenotypes of polycystic ovary syndrome. Eur J Endocrinol 175:551\u2013560. https:\/\/doi.org\/10.1530\/EJE-16-0775","journal-title":"Eur J Endocrinol"},{"key":"2946_CR24","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1530\/EJE-20-0725","volume":"184","author":"S Pandurevic","year":"2021","unstructured":"Pandurevic S, Bergamaschi L, Pizzi C et al (2021) Body mass index rather than the phenotype impacts precocious ultrasound cardiovascular risk markers in polycystic ovary syndrome. Eur J Endocrinol 184:199\u2013208. https:\/\/doi.org\/10.1530\/EJE-20-0725","journal-title":"Eur J Endocrinol"},{"key":"2946_CR25","doi-asserted-by":"publisher","first-page":"e3414","DOI":"10.1210\/clinem\/dgab380","volume":"106","author":"F Tosi","year":"2021","unstructured":"Tosi F, Villani M, Migazzi M et al (2021) Insulin-Mediated Substrate Use in Women With Different Phenotypes of PCOS: the Role of Androgens. J Clin Endocrinol Metab 106:e3414\u2013e3425. https:\/\/doi.org\/10.1210\/clinem\/dgab380","journal-title":"J Clin Endocrinol Metab"},{"key":"2946_CR26","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1038\/sj.ijo.0801994","volume":"26","author":"A Gambineri","year":"2002","unstructured":"Gambineri A, Pelusi C, Vicennati V et al (2002) Obesity and the polycystic ovary syndrome. Int J Obes Relat Metab Disord 26:883\u2013896. https:\/\/doi.org\/10.1038\/sj.ijo.0801994","journal-title":"Int J Obes Relat Metab Disord"},{"key":"2946_CR27","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1093\/ejendo\/lvag023","volume":"194","author":"S Broughton","year":"2026","unstructured":"Broughton S, Armeni E, Chu A et al (2026) The association between body image and well-being in polycystic ovary syndrome: a mixed-methods study. Eur J Endocrinol 194:233\u2013241. https:\/\/doi.org\/10.1093\/ejendo\/lvag023","journal-title":"Eur J Endocrinol"},{"key":"2946_CR28","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.jad.2019.05.006","volume":"253","author":"GS Kogure","year":"2019","unstructured":"Kogure GS, Ribeiro VB, Lopes IP et al (2019) Body image and its relationships with sexual functioning, anxiety, and depression in women with polycystic ovary syndrome. J Affect Disord 253:385\u2013393. https:\/\/doi.org\/10.1016\/j.jad.2019.05.006","journal-title":"J Affect Disord"},{"key":"2946_CR29","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.fertnstert.2019.06.018","volume":"112","author":"S Alur-Gupta","year":"2019","unstructured":"Alur-Gupta S, Chemerinski A, Liu C et al (2019) Body-image distress is increased in women with polycystic ovary syndrome and mediates depression and anxiety. Fertil Steril 112:930\u2013938e1. https:\/\/doi.org\/10.1016\/j.fertnstert.2019.06.018","journal-title":"Fertil Steril"},{"key":"2946_CR30","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1080\/09513590.2022.2118708","volume":"38","author":"S \u00c7etinkaya Altunta\u015f","year":"2022","unstructured":"\u00c7etinkaya Altunta\u015f S, \u00c7elik \u00d6, \u00d6zer \u00dc, \u00c7olak S (2022) Depression, anxiety, body image scores, and sexual dysfunction in patients with polycystic ovary syndrome according to phenotypes. Gynecol Endocrinol 38:849\u2013855. https:\/\/doi.org\/10.1080\/09513590.2022.2118708","journal-title":"Gynecol Endocrinol"},{"issue":"1","key":"2946_CR31","doi-asserted-by":"publisher","first-page":"qdaf335","DOI":"10.1093\/jsxmed\/qdaf335","volume":"23","author":"H Pastoor","year":"2026","unstructured":"Pastoor H, Laan EMT, Laven JSE, Both S (2026) Sexual function in women with Polycystic Ovary Syndrome: the role of psychological factors. J Sex Med 23(1):qdaf335. https:\/\/doi.org\/10.1093\/jsxmed\/qdaf335","journal-title":"J Sex Med"},{"issue":"3","key":"2946_CR32","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S2213-8587(24)00316-4","volume":"13","author":"F Rubino","year":"2025","unstructured":"Rubino F, Cummings DE, Eckel RH et al (2025) Definition and diagnostic criteria of clinical obesity. Lancet Diabetes Endocrinol 13(3):221\u2013262. https:\/\/doi.org\/10.1016\/S2213-8587(24)00316-4","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-026-02946-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-026-02946-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-026-02946-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T08:33:45Z","timestamp":1790757225000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-026-02946-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,28]]},"references-count":32,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["2946"],"URL":"https:\/\/doi.org\/10.1007\/s40618-026-02946-9","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,28]]},"assertion":[{"value":"22 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"AG reports receipt of fees for educational activities from Novo Nordisk and Neurocrine and participation in scientific advisory boards and\/or consultancy activities for Novo Nordisk and Eli Lilly; EM declares speaker honoraria for Novo Nordisk, Eli Lilly and New Penta Srl; LG reports receipt of fees for educational activities from Novo Nordisk; LV declares funding from the following companies for scientific research, advisory board attendance, and speaker honoraria: Theramex, Bayer-Schering Pharma, Ibsa Farmaceutici Italia, and Freya Pharma Solutions; The other authors declare no conflicts of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}